Komori
Yamada (6392) · RiskMitigated

Valuation fluctuations in investment securities

First written in FY2017. 12 of 25 entries say "Mitigated", first in FY2021-Q1. Latest entry: FY2026-H1.

25entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY2020-Q32017: 120172018: 220182019: 220192020: 420202021: 420212022: 320222023: 420232024: 320242025: 22025
Same theme, other companies
Market Price Risk on Held Financial InstrumentsA theme 351 companies write about · 350 as a headwind · 2 as a tailwind

The whole theme swung hardest in 2019: 56 of 138 companies on the "Worse" side.

31 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 354 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1MitigatedAnnual report

    「Valuation difference on available-for-sale securities 109,183 136,320」

    The valuation difference on available-for-sale securities increased from ¥109.183 million at the end of the previous fiscal year to ¥136.320 million, widening the positive valuation difference.
  2. FY2025MitigatedAnnual report

    「Valuation difference on available-for-sale securities 105,027 109,183」

    The valuation difference on available-for-sale securities increased from ¥105.027 million at the end of FY2024 to ¥109.183 million, widening the positive valuation difference.
  3. FY2025-H1Decline in the valuation difference on other securitiesAnnual report

    「Valuation difference on available-for-sale securities 105,027 94,145」

    The valuation difference on available-for-sale securities decreased from ¥105.027 million at the end of the previous fiscal year to ¥94.145 million, but remained positive.
  4. FY2024MitigatedAnnual report

    「Valuation difference on available-for-sale securities ¥105.027 million」

    The valuation difference on available-for-sale securities increased from ¥52.073 million in the previous year to ¥105.027 million, increasing the positive impact of fluctuations in the valuation of investment securities.
  5. FY2024-Q3MitigatedAnnual report

    「Valuation difference on available-for-sale securities ¥10.134 million ¥18.553 million」

    The valuation difference on available-for-sale securities increased from ¥10.134 million in the same period of the previous year to ¥18.553 million, increasing the positive impact of fluctuations in the valuation of investment securities.
  6. FY2024-Q2RestatedAnnual report

    「Regarding investment securities, the Group holds investment securities, and fluctuations in their valuation could have a material impact on the Group's operating results.」

    The risk that fluctuations in the valuation of investment securities will affect operating results continues to be disclosed.
  7. FY2024-Q1MitigatedAnnual report

    「Valuation difference on available-for-sale securities △ ¥7.200 million ¥15.185 million」

    The valuation difference on available-for-sale securities shifted from a negative ¥7.200 million in the same period of the previous year to a positive ¥15.185 million, improving the impact of fluctuations in the valuation of investment securities.
  8. FY2023MitigatedAnnual report

    「Valuation difference on available-for-sale securities △ ¥7.045 million ¥6.799 million」

    The valuation difference on available-for-sale securities improved from a negative ¥7.045 million in the previous year to a positive ¥6.799 million, improving the impact of fluctuations in the valuation of investment securities.
  9. FY2023-Q3MitigatedAnnual report

    「Valuation difference on available-for-sale securities △ ¥5.950 million ¥10.134 million」

    The valuation difference on available-for-sale securities improved from a negative ¥5.950 million in the same period of the previous year to a positive ¥10.134 million for the nine-month period ended in the third quarter, improving the impact of fluctuations in the valuation of investment securities.
  10. FY2023-Q2WorsenedAnnual report

    「Valuation difference on available-for-sale securities △ ¥3.973 million △ ¥6.039 million」

    The valuation difference on available-for-sale securities was a negative ¥6.039 million for the six-month period ended in the second quarter, compared with a negative ¥3.973 million in the same period of the previous year, increasing the negative impact of valuation fluctuations.
  11. FY2023-Q1MitigatedAnnual report

    「Valuation difference on available-for-sale securities △ ¥7.662 million △ ¥7.200 million」

    The negative valuation difference on available-for-sale securities narrowed from ¥7.662 million in the same period of the previous year to ¥7.200 million, slightly improving the impact of fluctuations in the valuation of investment securities.
  12. FY2022-Q3WorsenedAnnual report

    「Valuation difference on available-for-sale securities △ ¥5.950 million」

    The valuation difference on available-for-sale securities deteriorated from a negative ¥99 thousand in the same period of the previous year to a negative ¥5.950 million, increasing the negative impact of fluctuations in the valuation of investment securities.
  13. FY2022-Q2WorsenedAnnual report

    「Valuation difference on available-for-sale securities △ ¥3.973 million」

    The valuation difference on available-for-sale securities shifted from a positive ¥1.954 million in the same period of the previous year to a negative ¥3.973 million, worsening the impact of fluctuations in the valuation of investment securities.
  14. FY2022-Q1WorsenedAnnual report

    「Valuation difference on available-for-sale securities △ ¥7.662 million」

    The valuation difference on available-for-sale securities shifted from a positive ¥8.869 million in the same period of the previous year to a negative ¥7.662 million, and deterioration due to fluctuations in the valuation of investment securities actually occurred.
  15. FY2021MitigatedAnnual report

    「Valuation difference on available-for-sale securities ¥2.241 million」

    The valuation difference on available-for-sale securities improved from a negative ¥68.111 million in the previous year to a positive ¥2.241 million, reducing and improving the impact of investment securities valuation fluctuations on profit and loss. quantified=true, materialized=false.
  16. FY2021-Q3MitigatedAnnual report

    「Valuation difference on available-for-sale securities △ ¥99 thousand」

    The negative valuation difference on available-for-sale securities was ¥99 thousand, substantially narrowing from a negative ¥15.524 million in the same period of the previous year in terms of its impact on profit and loss.
  17. FY2021-Q2MitigatedAnnual report

    「Valuation difference on available-for-sale securities ¥1.954 million」

    The valuation difference on available-for-sale securities was positive at ¥1.954 million, improving from a negative ¥22.166 million in the same period of the previous year in terms of the impact of valuation fluctuations on profit and loss.
  18. FY2021-Q1MitigatedAnnual report

    「Valuation difference on available-for-sale securities ¥8.869 million」

    The valuation difference on available-for-sale securities was positive at ¥8.869 million for the quarter, improving from a negative ¥17.364 million in the same period of the previous year in terms of the impact of valuation differences on profit and loss.
  19. FY2020MaterialisedAnnual report

    「Valuation difference on available-for-sale securities △ ¥68.111 million」

    Fluctuations in the valuation of investment securities were reflected in a negative valuation difference on available-for-sale securities of ¥68.111 million, widening from a negative ¥31.407 million in the same period of the previous year.
  20. FY2020-Q3RestatedAnnual report

    「Regarding investment securities, the Group holds investment securities, and fluctuations in their valuation could have a material impact on the Group's operating results.」

    The risk that fluctuations in the valuation of investment securities will affect operating results continues to be disclosed.
  21. FY2020-Q2RestatedAnnual report

    「Regarding investment securities, the Group holds investment securities, and fluctuations in their valuation could have a material impact on the Group's operating results.」

    The risk that fluctuations in the valuation of investment securities will affect operating results continues to be disclosed.
  22. FY2019-Q3RestatedAnnual report

    「Regarding investment securities, the Group holds investment securities, and fluctuations in their valuation could have a material impact on the Group's operating results.」

    The risk that fluctuations in the valuation of investment securities will affect operating results continues to be disclosed.
  23. FY2019-Q2RestatedAnnual report

    「Regarding investment securities, the Group holds investment securities, and fluctuations in their valuation could have a material impact on the Group's operating results.」

    The risk that fluctuations in the valuation of investment securities will affect operating results continues to be disclosed.
  24. FY2019-Q1RestatedAnnual report

    「Regarding investment securities, the Group holds investment securities, and fluctuations in their valuation could have a material impact on the Group's operating results.」

    The risk that fluctuations in the valuation of investment securities will affect operating results continues to be disclosed.
  25. FY2017First statedAnnual report

    「The Group holds investment securities, and fluctuations in their valuation could have a significant impact on the Group's operating results.」

    Fluctuations in the valuation of investment securities are identified as a risk that could affect operating results.
Moved together

"Increase in the Equity Ratio" moved the same way as this thread, in the same document, in 12 of its 25 moves.

12109987★123456
  1. ★This thread
  2. 1Increase in the Equity Ratio12×
  3. 2Interim Dividend Payment10×
  4. 3Improving operating margin and ROE and reducing interest-bearing debt9×
  5. 4Impact of Yen Appreciation and Foreign-Exchange Fluctuations on the International Business9×
  6. 5Decline in Net Sales and Profit8×
  7. 6Accelerating new product development and infrastructure investment7×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Yamada's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.